Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression

References

• SilvermanMEFrom rebellious palpitations to the discovery of auricular fibrillation: contributions of Mackenzie, Lewis and EinthovenAm J Cardiol19947353843898109554
   PubMed Web of Science ®Google Scholar
• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
   PubMed Web of Science ®Google Scholar
• MiyasakaYBarnesMEGershBJSecular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalenceCirculation2006114211912516818816
   PubMed Web of Science ®Google Scholar
• SudlowMThomsonRThwaitesBRodgersHKennyRAPrevalence of atrial fibrillation and eligibility for anticoagulants in the communityLancet19983529135116711719777832
   PubMed Web of Science ®Google Scholar
• DavisRCHobbsFDKenkreJEPrevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES studyEuropace201214111553155922490371
   PubMed Web of Science ®Google Scholar
• LipGYBrechinCMLaneDAThe global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and EuropeChest201214261489149822459778
   PubMed Web of Science ®Google Scholar
• KrahnADManfredaJTateRBMathewsonFACuddyTEThe natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up StudyAm J Med19959854764847733127
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDMWangTJLeipEPLifetime risk for development of atrial fibrillation: the Framingham Heart StudyCirculation200411091042104615313941
   PubMed Web of Science ®Google Scholar
• HeeringaJvan der KuipDAHofmanAPrevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyEur Heart J200627894995316527828
   PubMed Web of Science ®Google Scholar
• HealeyJSConnollySJGoldMRSubclinical atrial fibrillation and the risk of strokeN Engl J Med2012366212012922236222
   PubMed Web of Science ®Google Scholar
• JabaudonDSztajzelJSievertKLandisTSztajzelRUsefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attackStroke20043571647165115155965
   PubMed Web of Science ®Google Scholar
• TayalAHTianMKellyKMAtrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or strokeNeurology200871211696170118815386
   PubMed Web of Science ®Google Scholar
• FusterVRydénLECannomDSAmerican College of Cardiology Foundation/American Heart Association Task Force2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesCirculation201112310e269e36721382897
   PubMed Web of Science ®Google Scholar
• BenjaminEJChenPSBildDEPrevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute workshopCirculation2009119460661819188521
   PubMed Web of Science ®Google Scholar
• KerrCRHumphriesKHTalajicMProgression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial FibrillationAm Heart J2005149348949615864238
   PubMed Web of Science ®Google Scholar
• de VosCBPistersRNieuwlaatRProgression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosisJ Am Coll Cardiol201055872573120170808
   PubMed Web of Science ®Google Scholar
• De VosCBBreithardtGCammAJProgression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapyAm Heart J2012163588789322607868
   PubMed Web of Science ®Google Scholar
• NieuwlaatRPrinsMHLe HeuzeyJYPrognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillationEur Heart J20082991181118918397874
   PubMed Web of Science ®Google Scholar
• YamashitaTInoueHOkumuraKRandomized trial of angiotensin II-receptor blocker vs dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study)Europace201113447347921148662
   PubMed Web of Science ®Google Scholar
• PapponeCRadinovicAMangusoFAtrial fibrillation progression and management: a 5-year prospective follow-up studyHeart Rhythm20085111501150718842464
   PubMed Web of Science ®Google Scholar
• TsangTSBarnesMEMiyasakaYObesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 yearsEur Heart J200829182227223318611964
   PubMed Web of Science ®Google Scholar
• Le HeuzeyJYBreithardtGCammJThe RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillationAm J Cardiol2010105568769320185018
   PubMed Web of Science ®Google Scholar
• JongnarangsinKSuwanagoolAChughAEffect of catheter ablation on progression of paroxysmal atrial fibrillationJ Cardiovasc Electrophysiol201223191421806697
   PubMed Web of Science ®Google Scholar
• CooperHABloomfieldDABushDERelation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study)Am J Cardiol200493101247125315135698
   PubMed Web of Science ®Google Scholar
• American College of Cardiology FoundationAmerican Heart AssociationEuropean Society of CardiologyHeart Rhythm SocietyManagement of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelinesCirculation2013127181916192623545139
   PubMed Web of Science ®Google Scholar
• GroenveldHFTijssenJGCrijnsHJRate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation)J Am Coll Cardiol201361774174823410544
   PubMed Web of Science ®Google Scholar
• BurashnikovADi DiegoJMZygmuntACBelardinelliLAntzelevitchCAtrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazineCirculation2007116131449145717785620
   PubMed Web of Science ®Google Scholar
• ZimetbaumPAntiarrhythmic drug therapy for atrial fibrillationCirculation2012125238138922249528
   PubMed Web of Science ®Google Scholar
• SokolowMQuinidine in the treatment of benign auricular fibrillation with repeated emboli: report of a caseAm Heart J1939184494499
   Google Scholar
• SödermarkTJonssonBOlssonAEffect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from StockholmBr Heart J19753754864921093559
   PubMedGoogle Scholar
• LloydEAGershBJFormanRThe efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placeboS Afr Med J198465103673696367096
   PubMed Web of Science ®Google Scholar
• KarlsonBWTorstenssonIAbjörnCJanssonSOPetersonLEDisopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up studyEur Heart J1988932842903289932
   PubMed Web of Science ®Google Scholar
• CrijnsHJGosselinkATLieKIPropafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study GroupCardiovasc Drugs Ther19961021451528842506
   PubMed Web of Science ®Google Scholar
• AliotEDenjoyIComparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study GroupAm J Cardiol199677366A71A
   PubMed Web of Science ®Google Scholar
• ChimientiMCullenMTJrCasadeiGSafety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study InvestigatorsAm J Cardiol199677360A75A
   PubMed Web of Science ®Google Scholar
• RoyDTalajicMDorianPAmiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation InvestigatorsN Engl J Med20003421391392010738049
   PubMed Web of Science ®Google Scholar
• SinghBNSinghSNRedaDJAmiodarone versus sotalol for atrial fibrillationN Engl J Med2005352181861187215872201
   PubMed Web of Science ®Google Scholar
• AFFIRM First Antiarrhythmic Drug Substudy InvestigatorsMaintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM sub-study of the first antiarrhythmic drugJ Am Coll Cardiol2003421202912849654
   PubMed Web of Science ®Google Scholar
• FreemantleNLafuente-LafuenteCMitchellSEckertLReynoldsMMixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillationEuropace201113332934521227948
   PubMed Web of Science ®Google Scholar
• Lafuente-LafuenteCMoulySLongás-TejeroMAMahéIBergmannJFAntiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trialsArch Intern Med2006166771972816606807
   PubMedGoogle Scholar
• VassalloPTrohmanRGPrescribing amiodarone: an evidence-based review of clinical indicationsJAMA2007298111312132217878423
   PubMed Web of Science ®Google Scholar
• SinghBNConnollySJCrijnsHJDronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterN Engl J Med20073571098799917804843
   PubMed Web of Science ®Google Scholar
• HohnloserSHCrijnsHJvan EickelsMATHENA InvestigatorsEffect of dronedarone on cardiovascular events in atrial fibrillationN Engl J Med2009360766867819213680
   PubMed Web of Science ®Google Scholar
• KøberLTorp-PedersenCMcMurrayJJIncreased mortality after dronedarone therapy for severe heart failureN Engl J Med2008358252678268718565860
   PubMed Web of Science ®Google Scholar
• ConnollySJCammAJHalperinJLDronedarone in high-risk permanent atrial fibrillationN Engl J Med2011365242268227622082198
   PubMed Web of Science ®Google Scholar
• CurtisABPractice Implications of the Atrial Fibrillation GuidelinesAm J Cardiol2013111111660167023507710
   PubMed Web of Science ®Google Scholar
• AndersonJLPrystowskyENSotalol: an important new antiarrhythmicAm Heart J1999137338840910047618
   PubMed Web of Science ®Google Scholar
• SinghSZobleRGYellenLEfficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) studyCirculation2000102192385239011067793
   PubMed Web of Science ®Google Scholar
• PedersenODBaggerHKellerNMarchantBKøberLTorp-PedersenCEfficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudyCirculation2001104329229611457747
   PubMed Web of Science ®Google Scholar
• OralHSouzaJJMichaudGFFacilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatmentN Engl J Med1999340241849185410369847
   PubMed Web of Science ®Google Scholar
• HongoRHThemistoclakisSRavieleAUse of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agentsJ Am Coll Cardiol200444486486815312873
   PubMed Web of Science ®Google Scholar
• ChiladakisJAKalogeropoulosAPatsourasNManolisASIbutilide added to propafenone for the conversion of atrial fibrillation and atrial flutterJ Am Coll Cardiol200444485986315312872
   PubMed Web of Science ®Google Scholar
• CammAJLipGYDe CaterinaR2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm AssociationEur Heart J201233212719274722922413
   PubMed Web of Science ®Google Scholar
• CalkinsHCatheter ablation to maintain sinus rhythmCirculation2012125111439144522431885
   PubMed Web of Science ®Google Scholar
• WazniOMMarroucheNFMartinDORadiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trialJAMA2005293212634264015928285
   PubMed Web of Science ®Google Scholar
• StabileGBertagliaESenatoreGCatheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)Eur Heart J200627221622116214831
   PubMed Web of Science ®Google Scholar
• PapponeCAugelloGSalaSA randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF StudyJ Am Coll Cardiol200648112340234717161267
   PubMed Web of Science ®Google Scholar
• NoheriaAKumarAWylieJVJrJosephsonMECatheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic reviewArch Intern Med2008168658158618362249
   PubMedGoogle Scholar
• Cosedis NielsenJJohannessenARaatikainenPRadiofrequency ablation as initial therapy in paroxysmal atrial fibrillationN Engl J Med2012367171587159523094720
   PubMed Web of Science ®Google Scholar
• ThackerELMcKnightBPsatyBMAssociation of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillationJ Gen Intern Med201328224725322972153
   PubMed Web of Science ®Google Scholar
• WangTJPariseHLevyDObesity and the risk of new-onset atrial fibrillationJAMA2004292202471247715562125
   PubMed Web of Science ®Google Scholar
• BitterTNölkerGVogtJPrinzCHorstkotteDOldenburgOPredictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathingJ Cardiovasc Electrophysiol2012231182521895831
   PubMed Web of Science ®Google Scholar
• PatelDMohantyPDi BiaseLSafety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressureCirc Arrhythm Electrophysiol20103544545120689107
   PubMed Web of Science ®Google Scholar
• CammAJBreithardtGCrijnsHReal-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)J Am Coll Cardiol201158549350121777747
   PubMed Web of Science ®Google Scholar
• LuZScherlagBJLinJAtrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacingCirc Arrhythm Electrophysiol20081318419219808412
   PubMed Web of Science ®Google Scholar
• HagensVEVan VeldhuisenDJKampOEffect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) studyHeart Rhythm200521192415851259
   PubMed Web of Science ®Google Scholar
• CalkinsHReynoldsMRSpectorPTreatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analysesCirc Arrhythm Electrophysiol20092434936119808490
   PubMed Web of Science ®Google Scholar
• PapponeCVicedominiGAugelloGRadiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF studyCirc Arrhythm Electrophysiol20114680881421946315
   PubMed Web of Science ®Google Scholar
• WeerasooriyaRKhairyPLitalienJCatheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?J Am Coll Cardiol201157216016621211687
   PubMed Web of Science ®Google Scholar
• OuyangFTilzRChunJLong-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-upCirculation2010122232368237721098450
   PubMed Web of Science ®Google Scholar
• HusseinAASalibaWIMartinDONatural history and long-term outcomes of ablated atrial fibrillationCirc Arrhythm Electrophysiol20114327127821493959
   PubMed Web of Science ®Google Scholar
• HsiehMHTaiCTTsaiCFClinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillationJ Cardiovasc Electrophysiol200314659860112875420
   PubMed Web of Science ®Google Scholar
• BertagliaETondoCDe SimoneADoes catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experienceEuropace201012218118719887458
   PubMed Web of Science ®Google Scholar